Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 76 Carcinoma, Non-Small-Cell Lung 73 Multiple Myeloma 58 Prostatic Neoplasms 57 Colorectal Neoplasms 45 Leukemia, Myeloid, Acute 43 Neoplasms 41 Melanoma 35 Lymphoma 35 Lung Neoplasms 32 Ovarian Neoplasms 31 Lymphoma, Non-Hodgkin 30 Squamous Cell Carcinoma of Head and Neck 29 Sarcoma 28 Neoplasm Metastasis 27 Pancreatic Neoplasms 26 Endometrial Neoplasms 25 Carcinoma, Hepatocellular 25 Hodgkin Disease 23 Carcinoma, Renal Cell 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 22 Lymphoma, Large B-Cell, Diffuse 22 Leukemia, Lymphocytic, Chronic, B-Cell 22 Glioma 22 Recurrence 21 Urinary Bladder Neoplasms 20 Myelodysplastic Syndromes 20 Head and Neck Neoplasms 20 Esophageal Neoplasms 17 Stomach Neoplasms 16

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Opioid-Related Disorders × 30 days × Clear all

NCT06651177 2026-05-22

TAB

University of Cincinnati

Phase 2 Recruiting

Lymphoma, Follicular, Opioid-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡